The European healthcare CDMO market is projected to grow at a significant CAGR during the forecast period (2020-2026). The increasing demand for innovations in drug development for better productivity in pharmaceutical production and reliable research is leading to outsourcing within the region.
Browse the full report description European Healthcare Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Trends Analysis Report by Services (Contract Development and Contract Manufacturing) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/europe-healthcare-cdmo-market
Further, the increasing expenditure in the healthcare sector by European countries has also been observed. This is the major factor driving the growth of the European pharmaceutical contract manufacturing industry that propels the CDMO market. Additionally, contract manufacturing and research activities are pacing up to cater to the ever-increasing demands by the healthcare industry to provide advanced treatment options in Europe.
Moreover, the presence of global leader biotech companies including GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and other major biopharmaceutical companies in Europe makes it one of the leading markets in the global life science industry. The rise in R&D investment by these market players would significantly contribute to the growth of the European pharmaceuticals contract manufacturing market. AstraZeneca PLC has spent a large amount of fund of around $5.6 billion for R&D during 2016-2017.
Europe has made significant R&D in pharmaceuticals mainly due to the increasing drug discovery and research, and growing demand for innovative drugs. Additionally, the increasing investment of the government in the life sciences and biopharmaceuticals is further augmenting the growth of the market in the region.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2019-2026 |
|
Base year |
2019 |
|
Forecast period |
2020-2026 |
|
Segments Covered |
By Services |
|
Regions Covered |
UK, Germany, France, Italy, Spain, and the Rest of Europe |
|
Key Companies Profiled |
Almac Group Ltd., B. Braun Melsungen AG, Boehringer Ingelheim
International GmbH, Jubilant
Life Sciences Ltd., Lonza
Group Ltd., Recipharm AB, and others |
Key Questions Addressed by the Report
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
o Recommendations
European healthcare CDMO Market – Segmentation
By Services
o Clinical
o Preclinical
o Laboratory Services
o Active Pharmaceutical Ingredients (API)
o Finish Dosage Formulations
o Medical Devices
European Healthcare CDMO Market – Segmentation by Region
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/europe-healthcare-cdmo-market